oliver_brandicourt_bayer

Oliver Brandicourt joins Bayer from Pfizer

pharmafile | September 30, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Pfizer 

Bayer Healthcare has appointed Pfizer’s executive Olivier Brandicourt to head up its healthcare division.

Taking over from interim head Wolfgang Plischke from 1 Nov, Germany’s biggest drug firm said Brandicourt, who was a member of Pfizer’s executive leadership team, will be responsible for taking new drugs to market.

The previous head of Bayer, Joerg Reinhardt, resigned in February to become chairman of Novartis .

Advertisement

“With Olivier Brandicourt we have found a strong leader with outstanding international experience and a successful track record in the healthcare industry,” said Bayer chief executive Marijn Dekkers.

Speaking about his new role, Brandicourt said he was: “Looking forward to joining the Bayer team”, adding that the group has a clear focus on research and development as well as a passion and dedication to improving people’s lives.

Related Content

Evotec and Bayer announce new kidney disease study

Evotec and Bayer have announced the initiation of a phase 2 clinical study in kidney …

NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS

Walton Oaks, 21st May 2025 – Pfizer Ltd announced today that the National Institute for Health and Care …

Third application for Orion’s prostate cancer drug submitted by partner Bayer

Finnish pharmaceutical company Orion has announced that its partner Bayer is applying for a third application …

The Gateway to Local Adoption Series

Latest content